osteoimplant
Phase 1Small molecule
osteoimplant is one of 5 small molecule programs targeting Healing. It is currently in Phase 1.
1
Indications
1
Total Trials
1
Active Trials
4
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
6 competitors in Healing
#DrugCompanyPhaseTrials
1Carafate
AbbVieApproved
Nexium
DDexcel Pharma Technologies Ltd.
Approved
Psilocybin
COMPASS PathwaysPhase 1
Platelet Rich Fibrin
GGovernment Dental College and Research Institute, Bangalore
Preclinical
osteoimplant
UUniversidad de Granada
Phase 1
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for osteoimplant. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 1[1]
- Company
- UUniversidad de Granada